Status:

COMPLETED

Trial to Define the Benefits and Harms of Deceased Donor Kidney Procurement Biopsies

Lead Sponsor:

St. Louis University

Collaborating Sponsors:

Mid-America Transplant

Washington University School of Medicine

Conditions:

Kidney Transplant

Renal Transplant

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

The purpose of this research study is to compare the impact of the availability of biopsy results at the time of organ offers on the use and outcomes of kidneys from deceased donors.

Detailed Description

Randomization of biopsy processing will be performed at the level of the deceased donor. If the participant agrees to be in this study and signs the informed consent, at the time that a kidney is acc...

Eligibility Criteria

Inclusion

  • Kidney transplant candidate
  • On waitlist for kidney transplant at the time of informed consent at one of the participating sites
  • Age 18 or older
  • Willing and able to provide informed consent for participation in the study

Exclusion

  • Unable or unwilling to provide informed consent to participate in the study
  • Younger than 18 years old
  • Not on waitlist for kidney transplant at the time of informed consent at one of the participating centers
  • Candidates for or recipients of multi-organ transplants (kidney along with another solid organ)

Key Trial Info

Start Date :

September 17 2019

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

February 4 2023

Estimated Enrollment :

12 Patients enrolled

Trial Details

Trial ID

NCT03837522

Start Date

September 17 2019

End Date

February 4 2023

Last Update

March 30 2023

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Saint Louis University

St Louis, Missouri, United States, 63110

2

Washington University

St Louis, Missouri, United States, 63110

Trial to Define the Benefits and Harms of Deceased Donor Kidney Procurement Biopsies | DecenTrialz